202 related articles for article (PubMed ID: 9301984)
1. Antibacterial properties of BO-2727, a new carbapenem antibiotic.
Kato Y; Otsuki M; Nishino T
J Antimicrob Chemother; 1997 Aug; 40(2):195-203. PubMed ID: 9301984
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo antibacterial activities of BO-2727, a new carbapenem.
Asahi Y; Miyazaki S; Yamaguchi K
Antimicrob Agents Chemother; 1995 May; 39(5):1030-7. PubMed ID: 7625784
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem.
Koga T; Abe T; Inoue H; Takenouchi T; Kitayama A; Yoshida T; Masuda N; Sugihara C; Kakuta M; Nakagawa M; Shibayama T; Matsushita Y; Hirota T; Ohya S; Utsui Y; Fukuoka T; Kuwahara S
Antimicrob Agents Chemother; 2005 Aug; 49(8):3239-50. PubMed ID: 16048932
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo evaluation of BO-2727 against imipenem- and/or meropenem-resistant Pseudomonas aeruginosa.
Shibata K; Adachi Y; Kato E; Nagano R; Fuse A; Hashizume T; Ohtake N; Okamoto O; Nakagawa S
J Antibiot (Tokyo); 1997 Feb; 50(2):135-8. PubMed ID: 9099222
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of a new carbapenem antibiotic, BO-2727, with potent antipseudomonal activity.
Nakagawa S; Hashizume T; Matsuda K; Sanada M; Okamoto O; Fukatsu H; Tanaka N
Antimicrob Agents Chemother; 1993 Dec; 37(12):2756-9. PubMed ID: 8109950
[TBL] [Abstract][Full Text] [Related]
6. CW-270033, a novel pyrrolidinyl-thio carbapenem, has potent antimicrobial activity in vitro and in vivo.
Kim J; Ha JR; Oh SW; Kim HG; Lee JM; Lee DG; Lee SH; Kim JG
Biol Pharm Bull; 2007 Mar; 30(3):575-9. PubMed ID: 17329859
[TBL] [Abstract][Full Text] [Related]
7. Affinities of BO-2727 for bacterial penicillin-binding proteins and morphological change of gram-negative rods.
Hashizume T; Nakamura K; Nakagawa S
J Antibiot (Tokyo); 1997 Feb; 50(2):139-42. PubMed ID: 9099223
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo antibacterial activities of meropenem, a new carbapenem antibiotic.
Harabe E; Kawai Y; Kanazawa K; Otsuki M; Nishino T
Drugs Exp Clin Res; 1992; 18(2):37-46. PubMed ID: 1644010
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of BO-3482, a novel dithiocarbamate carbapenem with activity against methicillin-resistant staphylococci.
Adachi Y; Nakamura K; Kato Y; Hazumi N; Hashizume T; Nakagawa S
Antimicrob Agents Chemother; 1997 Oct; 41(10):2282-5. PubMed ID: 9333063
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro activity of S-4661, a new parenteral carbapenem, and other antimicrobial agents against respiratory pathogens.
Watanabe A; Takahashi H; Kikuchi T; Kobayashi T; Gomi K; Fujimura S; Tokue Y; Nukiwa T
Chemotherapy; 2000; 46(3):184-7. PubMed ID: 10765033
[TBL] [Abstract][Full Text] [Related]
11. In-vitro activity of meropenem imipenem, the penem HRE 664 and ceftazidine against clinical isolates from West Germany.
Bauernfeind A; Jungwirth R; Schweighart S
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():73-84. PubMed ID: 2509418
[TBL] [Abstract][Full Text] [Related]
12. In vitro antibacterial activity and beta-lactamase stability of a new carbapenem, BO-2727.
Inoue K; Hamana Y; Mitsuhashi S
Antimicrob Agents Chemother; 1995 Oct; 39(10):2331-6. PubMed ID: 8619591
[TBL] [Abstract][Full Text] [Related]
13. [Antimicrobial susceptibilities of organisms isolated from patients with urinary tract infections in 2002].
Eta S; Kawahara M
Jpn J Antibiot; 2006 Feb; 59(1):21-8. PubMed ID: 16673579
[TBL] [Abstract][Full Text] [Related]
14. [Preclinical evaluation of meropenem, a new parenteral carbapenem].
Edwards JR
New Microbiol; 1995 Oct; 18 Suppl():19S-31S. PubMed ID: 8574929
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo antibacterial activities of SM-216601, a new broad-spectrum parenteral carbapenem.
Ueda Y; Kanazawa K; Eguchi K; Takemoto K; Eriguchi Y; Sunagawa M
Antimicrob Agents Chemother; 2005 Oct; 49(10):4185-96. PubMed ID: 16189097
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo antibacterial activities of ER-35786, a new antipseudomonal carbapenem.
Ohba F; Nakamura-Kamijo M; Watanabe N; Katsu K
Antimicrob Agents Chemother; 1997 Feb; 41(2):298-307. PubMed ID: 9021183
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I.
Ubukata K; Hikida M; Yoshida M; Nishiki K; Furukawa Y; Tashiro K; Konno M; Mitsuhashi S
Antimicrob Agents Chemother; 1990 Jun; 34(6):994-1000. PubMed ID: 2203313
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo antibacterial activities of a new carbapenem BO-2727 for use in obstetrics and gynecology.
Mikamo H; Kawazoe K; Izumi K; Sato Y; Tamaya T
Chemotherapy; 1998; 44(1):12-6. PubMed ID: 9444403
[TBL] [Abstract][Full Text] [Related]
19. [Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study].
Korten V; Söyletir G; Yalçın AN; Oğünç D; Dokuzoğuz B; Esener H; Ulusoy S; Tünger A; Aygen B; Sümerkan B; Arman D; Dizbay M; Akova M; Hasçelik G; Eraksoy H; Başaran S; Köksal I; Bayramoğlu G; Akalın H; Sınırtaş M
Mikrobiyol Bul; 2011 Apr; 45(2):197-209. PubMed ID: 21644063
[TBL] [Abstract][Full Text] [Related]
20. [In vitro and in vivo antibacterial activities of pazufloxacin mesilate, a new injectable quinolone].
Nomura N; Mitsuyama J; Furuta Y; Yamada H; Nakata M; Fukuda T; Yamada H; Takahata M; Minami S
Jpn J Antibiot; 2002 Aug; 55(4):412-39. PubMed ID: 12378871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
